5 December 2022
Supporting cell gene therapy through multimodal flexible facilities
Cell and gene therapies (C>) have unique needs in manufacturing suites that differ from those for classic product biopharmaceuticals. Facilities must be created with flexibility in mind, able to run multiple products and production types to remain viable.
2 December 2022
Arcadis completes the acquisition of DPS group creating a leading position in the life sciences and semiconductor manufacturing market
DPS’s high growth and resilient Life Sciences and Semiconductor manufacturing expertise will become part of Arcadis’ Places Global Business Area (GBA) • Arcadis adds an extra 2,850 talented employees to its growing business